Drugs · acquisition-cost intelligence
FIRVANQ
vancomycin hydrochloride· ingredient vancomycinAntibiotics
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.62146
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 8 weeks.
2025-09-172026-05-20
Same-ingredient options by acquisition cost
Other vancomycin products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Vancomycin Hydrochloride | $0.68721 | +$0.06570 |
| vancomycin hydrochloride | $2.13 | +$1.51 |
Medicare Part D coverage · CY2026
On 48 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 19% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.